These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 31152801

  • 1. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 2. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 3. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
    Stürznickel J, Schmidt FN, von Vopelius E, Delsmann MM, Schmidt C, Jandl NM, Oheim R, Barvencik F.
    Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
    [Abstract] [Full Text] [Related]

  • 4. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 5. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 7. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 10; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 8. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 9. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH.
    Lancet Diabetes Endocrinol; 2019 Feb 16; 7(2):93-105. PubMed ID: 30558909
    [Abstract] [Full Text] [Related]

  • 10. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Feb 16; 29(2):511-515. PubMed ID: 29046930
    [Abstract] [Full Text] [Related]

  • 11. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.
    Freitas TQ, Franco AS, Pereira RMR.
    Medicine (Baltimore); 2018 Nov 16; 97(48):e13210. PubMed ID: 30508901
    [Abstract] [Full Text] [Related]

  • 12. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ.
    BioDrugs; 2016 Feb 16; 30(1):41-8. PubMed ID: 26832358
    [Abstract] [Full Text] [Related]

  • 13. Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data.
    Simmons JH, Rush ET, Petryk A, Zhou S, Martos-Moreno GÁ.
    Bone; 2020 Aug 16; 137():115413. PubMed ID: 32417537
    [Abstract] [Full Text] [Related]

  • 14. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H, Yasuda S, Kakoi S, Ohata Y, Shimizu Y, Hasegawa C, Hayakawa A, Akiyama T, Yagi T, Aotani D, Imaeda K, Ozono K, Kataoka H, Tanaka T.
    Intern Med; 2020 Mar 15; 59(6):811-815. PubMed ID: 31787692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.
    Seefried L, Rak D, Petryk A, Genest F.
    Osteoporos Int; 2021 Dec 15; 32(12):2505-2513. PubMed ID: 34215909
    [Abstract] [Full Text] [Related]

  • 17. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.
    J Clin Endocrinol Metab; 2016 Jan 15; 101(1):334-42. PubMed ID: 26529632
    [Abstract] [Full Text] [Related]

  • 18. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C, Seefried L, Jakob F.
    Drugs Today (Barc); 2016 May 15; 52(5):271-85. PubMed ID: 27376160
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impressive clinical improvement and disappearance of neuropathic pain in an adult patient with hypophosphatasia treated with asfotase alfa.
    Zervou Z, Plooij R, van Velsen EFS, Timmermans RGM, Demirdas S, Zillikens MC.
    Eur J Med Genet; 2024 Apr 15; 68():104915. PubMed ID: 38325645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.